newsfilter
← Latest News
GlobeNewswire·

UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026

PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers,